Innovative Follow-up Strategies for Endometrial Cancer

被引：8
作者：
Collins, A. [1 ]
Taylor, A. [2 ]
Guttery, D. S. [1 ]
Moss, E. L. [1 ]
机构：
[1] Univ Leicester, Leicester Canc Res Ctr, Leicester LE2 7LX, Leics, England
[2] Royal Marsden NHS Fdn Trust, London, England
来源：
CLINICAL ONCOLOGY | 2021年 / 33卷 / 09期
关键词：
Cancer survivorship; circulating tumour DNA; endometrial cancer; patient-initiated follow-up; recurrence; telephone follow-up; CIRCULATING TUMOR DNA; QUALITY-OF-LIFE; GYNECOLOGICAL MALIGNANCY; COST-EFFECTIVENESS; RECURRENCE; DIAGNOSIS; WOMEN; SURVEILLANCE; SURVIVORS; PATTERNS;
D O I：
10.1016/j.clon.2021.06.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Increasing recognition of the heterogeneous nature of endometrial cancer, the excellent prognosis of low-risk cases and improvements in risk stratification offer opportunities for innovative, personalised follow-up strategies. This review article outlines the evidence base for alternative follow-up strategies in the different risk categories of endometrial cancer, cancer survivorship programmes and considers future directions in endometrial cancer follow-up, including emerging new techniques, such as the liquid biopsy, and opportunities for combining molecular and clinicopathological features to personalise endometrial cancer follow-up. (c) 2021 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：E383 / E392
页数：10
相关论文
共 74 条
  • [1] Abbink K., 2018, TUMOR BIOL, V40, p1010428318757103, DOI DOI 10.1177/1010428318757103
  • [2] Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women
    Audet-Delage, Yannick
    Villeneuve, Lyne
    Gregoire, Jean
    Plante, Marie
    Guillemette, Chantal
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [3] Comparing hospital and telephone follow-up for patients treated for stage-I endometrial cancer (ENDCAT trial): a randomised, multicentre, non-inferiority trial
    Beaver, K.
    Williamson, S.
    Sutton, C.
    Hollingworth, W.
    Gardner, A.
    Allton, B.
    Abdel-Aty, M.
    Blackwood, K.
    Burns, S.
    Curwen, D.
    Ghani, R.
    Keating, P.
    Murray, S.
    Tomlinson, A.
    Walker, B.
    Willett, M.
    Wood, N.
    Martin-Hirsch, P.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2017, 124 (01) : 150 - 160
  • [4] Exploring the acceptability and feasibility of patient-initiated follow-up for women treated for stage I endometrial cancer
    Beaver, Kinta
    Martin-Hirsch, Pierre
    Williamson, Susan
    Kyrgiou, Maria
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2020, 44
  • [5] A systematic literature review of trials of survivorship interventions for women with gynaecological cancer and their caregivers
    Beesley, Vanessa L.
    Alemayehu, Chalachew
    Webb, Penelope M.
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2019, 28 (03)
  • [6] A systematic literature review of the prevalence of and risk factors for supportive care needs among women with gynaecological cancer and their caregivers
    Beesley, Vanessa L.
    Alemayehu, Chalachew
    Webb, Penelope M.
    [J]. SUPPORTIVE CARE IN CANCER, 2018, 26 (03) : 701 - 710
  • [7] Patterns of recurrence and outcomes in surgically treated women with endometrial cancer according to ESMO-ESGO-ESTRO Consensus Conference risk groups: Results from the FRANCOGYN study Group
    Bendifallah, Sofiane
    Ouldamer, Lobna
    Lavoue, Vincent
    Canlorbe, Geoffroy
    Raimond, Emilie
    Coutant, Charles
    Graesslin, Olivier
    Touboul, Cyril
    Collinet, Pierre
    Darai, Emile
    Ballester, Marcos
    [J]. GYNECOLOGIC ONCOLOGY, 2017, 144 (01) : 107 - 112
  • [8] BGCS, BGCS FRAM CAR PAT GY
  • [9] Targeted next-generation sequencing of endometrial cancer and matched circulating tumor DNA: identification of plasma-based, tumor-associated mutations in early stage patients
    Bolivar, Ana M.
    Luthra, Rajyalakshmi
    Mehrotra, Meenakshi
    Chen, Wei
    Barkoh, Bedia A.
    Hu, Peter
    Zhang, Wei
    Broaddus, Russell R.
    [J]. MODERN PATHOLOGY, 2019, 32 (03) : 405 - 414
  • [10] Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
    Brennan, Donal J.
    Hackethal, Andreas
    Mann, Kristy P.
    Mutz-Dehbalaie, Irene
    Fiegl, Heidi
    Marth, Christian
    Obermair, Andreas
    [J]. BMC CANCER, 2015, 15
12345678